PMDA drug package insert
スキャンドネストカートリッジ3%
PMDA Prescription drug · 日本歯科薬品株式会社 · package insert Aug 8, 2024
Key facts
| Brand names | スキャンドネストカートリッジ3% |
|---|---|
| Nonproprietary names | メピバカイン塩酸塩 |
| Companies | 製造販売元／日本歯科薬品株式会社, 製造元／セプトドント社 Septodont |
| Product type | Prescription drug |
| Therapeutic category | 歯科用局所麻酔剤 |
| Therapeutic category codes | 87271 |
| YJ codes | 2710810U3020 |
| Approval numbers | 21300AMY00484000 |
| Package insert edition | 第2版 |
| Package insert date | Aug 8, 2024 |
| PMDA document key | 530244_2710810U3020_1 |
| PMDA company code | 530244 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: